Abstract
DRG neurones are a heterogeneous population of neurones that vary in sensory transduction mechanisms, myelination, axon diameter, cell soma size, neurotransmitter content, receptor and ion channel expression. The generation, conduction, integration and transmission of pain signals begin in DRG neurones and they remain an important target for therapeutic intervention in pain disorders. In this review we discuss the expression of cannabinoid receptors in DRG neurones. We will also discuss the actions and molecular mechanisms of cannabinoid receptor ligands in the context of modulating sensory neurone excitability. Evidence suggests that vanilloid and cytokine receptor functions, voltageactivated Ca2+ and K + channels and Ca2+-activated channels are all either direct or indirect sites that might be modulated by synthetic and endogenous cannabinoid ligands.
Keywords: Neurones, heterogeneous, myelination
Current Neuropharmacology
Title: Cannabinoids and Sensory Neurones
Volume: 2 Issue: 1
Author(s): Ruth A. Ross, Rhian M. Evans and Roderick H. Scott
Affiliation:
Keywords: Neurones, heterogeneous, myelination
Abstract: DRG neurones are a heterogeneous population of neurones that vary in sensory transduction mechanisms, myelination, axon diameter, cell soma size, neurotransmitter content, receptor and ion channel expression. The generation, conduction, integration and transmission of pain signals begin in DRG neurones and they remain an important target for therapeutic intervention in pain disorders. In this review we discuss the expression of cannabinoid receptors in DRG neurones. We will also discuss the actions and molecular mechanisms of cannabinoid receptor ligands in the context of modulating sensory neurone excitability. Evidence suggests that vanilloid and cytokine receptor functions, voltageactivated Ca2+ and K + channels and Ca2+-activated channels are all either direct or indirect sites that might be modulated by synthetic and endogenous cannabinoid ligands.
Export Options
About this article
Cite this article as:
Ross A. Ruth, Evans M. Rhian and Scott H. Roderick, Cannabinoids and Sensory Neurones, Current Neuropharmacology 2004; 2 (1) . https://dx.doi.org/10.2174/1570159043476882
DOI https://dx.doi.org/10.2174/1570159043476882 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer Cells
Current Drug Targets MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases
Current Genomics Transposable Elements in Cancer and Other Human Diseases
Current Cancer Drug Targets Peptide modules for overcoming barriers of nucleic acids transport to cells
Current Topics in Medicinal Chemistry Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Current Pharmaceutical Design Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Fluorine-18 Labeled Amino Acids for Oncologic Imaging with Positron Emission Tomography
Current Topics in Medicinal Chemistry Polysialyltransferase: A New Target in Metastatic Cancer
Current Cancer Drug Targets Telomeric Repeat Containing RNA (TERRA): Aging and Cancer
CNS & Neurological Disorders - Drug Targets Modulation of Nitric Oxide Pathway by Multiligands/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes
Current Enzyme Inhibition The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
Current Medicinal Chemistry Synthesis of [DTPA-bis(D-ser)] Chelate (DBDSC): An Approach for the Design of SPECT Radiopharmaceuticals Based on Technetium
Current Radiopharmaceuticals Rho as a Target to Promote Repair: Translation to Clinical Studies with Cethrin
Current Pharmaceutical Design Phagoptosis - Cell Death By Phagocytosis - Plays Central Roles in Physiology, Host Defense and Pathology
Current Molecular Medicine A Comprehensive Insight Towards Pharmaceutical Aspects of Graphene Nanosheets
Current Pharmaceutical Biotechnology Targeting miR-21 Induces Autophagy and Chemosensitivity of Leukemia Cells
Current Drug Targets Identification of WHO II/III Gliomas by 16 Prognostic-related Gene Signatures using Machine Learning Methods
Current Medicinal Chemistry Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Oncogene-Directed Therapies as Modulators of Cancer Coagulopathy, Angiogenesis and Tumor-Vascular Interface
Current Signal Transduction Therapy Roles of EGFR, PI3K, AKT, and mTOR in Heavy Metal-Induced Cancer
Current Cancer Drug Targets